Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Lightpath Technologies Divestiture to Hengtu Optical Technology Co., Ltd.
LightPath Technologies completed the sale of its wholly owned Chinese subsidiary, LightPath (Zhenjiang) Optical Instrumentation Co., Ltd. (LPOIZ), to Hengtu Optical Technology Co., Ltd. The divestiture removes all of LightPath's manufacturing operations from China, aligning its footprint entirely within the U.S. and Europe to better serve defense and commercial customers requiring non-China sourcing.
Astrana Health reported record third-quarter 2026 revenue of $1.02 billion, a 7% increase year-over-year, and record adjusted EBITDA of $77.2 million. Net income attributable to the company rose significantly to $13.0 million, or $0.26 per diluted share, driven by the execution of its AI-native healthcare operating platform.
Term
Q3 2026
“Our third quarter results demonstrate the growing impact of Astrana’s physician-centric, AI-native healthcare operating platform and our team’s continued focus on execution. We delivered record revenue, record adjusted EBITDA, and double-digit organic earnings growth while continuing to invest in the next phase of our growth.”
Brandon Sim, President and Chief Executive Officer
“By combining proprietary technology, aligned physician partnerships, and integrated care delivery, we’re building a scalable, repeatable model to improve patient outcomes and manage the total cost of care – a value proposition that extends across payer and reimbursement models and positions us to create sustainable long-term value for patients, physician partners, and shareholders.”
Brandon Sim, President and Chief Executive Officer
Wolfspeed, Inc. reported a net loss of $143.8 million for the quarter ended September 27, 2026, on revenue of $155.0 million, which declined from $196.8 million in the prior year period. The company emerged from Chapter 11 bankruptcy on September 29, 2025, adopting fresh-start accounting and resulting in a new financial reporting basis for the 'Successor' entity.
Kingsway Corp reported total revenue of $38.9 million for Q3 2026, up from $36.8 million in the prior year period. The company experienced a net loss attributable to common shareholders for the quarter, resulting in basic and diluted loss per share of $0.01. Potentially dilutive securities were excluded from calculations as their inclusion would have been anti-dilutive due to the net loss.
Matrix Service Company reported a return to profitability for the quarter ended September 30, 2026, with net income of $6.2 million compared to a net loss of $3.7 million in the prior year period. Revenue increased slightly to $219.4 million, while operating income improved significantly due to higher gross profits and a reduction in selling, general, and administrative expenses.
California BanCorp's Board of Directors authorized an increase of 1.6 million shares to its existing share repurchase program, doubling the total authorization to 3.2 million shares. The additional authorization represents approximately 5.0% of the company's outstanding common stock and has no expiration date. Since the program's inception, the company has already repurchased over 1 million shares for approximately $19.7 million.
AEye reported Q3 2026 revenue of $506 thousand, a 10x increase year-over-year, driven by its expanding customer base which grew to 32 revenue-generating clients. The company recorded its first STRATOS revenue and began recognizing revenue from its multi-million-dollar lunar terrain vehicle agreement with Lunar Outpost.
Term
Q3 2026
“Our success with leveraging our software-defined architecture into new commercial agreements across a wider range of addressable markets is reflected in our accelerating revenue growth. A growing number of customers are choosing AEye for demanding applications that require long-range detection, rugged hardware, and the ability to adapt sensing behavior as their requirements evolve.”
Matt Fisch, CEO of AEye
“We have a growing number of qualified leads entering our pipeline, a record number of customers integrating and validating our software-defined architecture, and we are translating this into a growing number of new commercial engagements. We expect to continue converting our record pipeline into sustained commercial activity, leading to significant revenue growth anticipated in 2027.”
Applied Optoelectronics reported record Q3 2026 revenue of $269.9 million, a significant increase from $118.6 million in the prior year, and returned to GAAP profitability. The company highlighted strong demand for its 800G and 1.6T optical products driven by AI datacenter deployments and announced a multi-year strategic agreement with a Tier 1 hyperscale customer.
Term
Q3 2026
“We are pleased to have generated record revenue for our sixth consecutive quarter and to have returned to GAAP profitability in Q3. We have made meaningful progress in scaling our manufacturing capabilities, particularly for our 800G and 1.6T products, to address demand for AI-related optical technologies that we believe is accelerating.”
Dr. Thompson Lin, AOI’s Founder, President and Chief Executive Officer
“We delivered another solid quarter, including accelerating revenue growth and improving profitability, driven by robust demand and manufacturing expansion in both our datacenter and CATV businesses.”
Dr. Stefan Murry, AOI’s Chief Financial Officer and Chief Strategy Officer
Ingevity Corp reported a net income of $49.3 million for the quarter ended September 30, 2026, compared to $43.5 million in the prior year period. While net sales decreased from $333.1 million to $305.1 million, the company saw a significant recovery in nine-month net income ($144.4 million) compared to a net loss in 2025, largely due to the absence of prior-year goodwill impairment charges.
KLX Energy Services reported Q3 2026 revenue of $186 million, exceeding the high end of its guidance range and representing an 11% sequential increase. The company also highlighted the completion of a backstopped rights offering that converted $87.8 million of debt to equity and raised $37.2 million in new capital, significantly strengthening its balance sheet.
Term
Q3 2026
“Our third quarter results demonstrate the earnings potential of the KLX platform when activity, mix and execution align. Revenue was $186 million, above the high end of our guidance range and up $18 million, or 11%, sequentially, outpacing the 7% increase in the average Lower 48 land rig count.”
Chris Baker, KLX President and Chief Executive Officer
“We made meaningful progress on the three priorities we outlined exiting the second quarter. First, we strengthened our balance sheet through the successful completion of the Backstopped Rights Offering, converting $87.8 million of debt to equity and raising $37.2 million of new equity.”
Chris Baker, KLX President and Chief Executive Officer
Green Plains Inc. reported record third quarter 2026 results with net income of $85.4 million and record adjusted EBITDA of $118.0 million, significantly boosted by $65.4 million in 45Z production tax credit value. The company also announced it executed an agreement on October 29, 2026, to monetize between $250 million and $325 million of its 2026 45Z tax credits.
Term
Q3 2026
“Green Plains delivered record operating performance across the platform in the third quarter, demonstrating the earnings power we’ve built across the business. Following quarter-end, the execution of our 45Z monetization agreement marked another important milestone by providing greater visibility into converting that value into cash. Together, a stronger base business and increased financial flexibility position us to invest in our platform and pursue opportunities where we believe Green Plains can create additional value for shareholders.”
Chris Osowski, President and Chief Executive Officer of Green Plains
“Our strong cash position and free cash flow allow us to explore a variety of options, but our standards for deploying capital have not changed. Every opportunity will be evaluated against risk-adjusted returns, strategic fit, and its ability to create long-term value. We intend to remain disciplined and selective as we determine where the next dollar of capital can generate attractive returns.”
NerdWallet reported revenue of $239.6 million for the third quarter of 2026, a 11% increase year-over-year, with net income of $14.9 million. For the nine months ended September 30, 2026, the company achieved a net income of $39.6 million compared to $34.7 million in the prior year, despite an increase in sales and marketing expenses.
Westrock Coffee reported third quarter 2026 results with net sales of $300.2 million and a net loss of $10.0 million, an improvement from the prior year's $19.1 million loss. The company achieved its sixth consecutive quarter of year-over-year Adjusted EBITDA growth, reaching $26.4 million, and recently completed a $600 million refinancing of its credit facilities.
Term
Q3 2026
“The third quarter was another record quarter for Westrock Coffee, as it was the sixth consecutive quarter of year-over-year Consolidated Adjusted EBITDA growth. We are growing, we are generating cash, and with the recently closed Beverage Solutions credit agreement, we have put the balance sheet on solid footing for the long-term.”
Organogenesis Holdings Inc. reported third quarter 2026 financial results, showing a significant 70% year-over-year revenue decline to $45.5 million. The company posted a net loss of $29.6 million as it navigates what management described as a 'market reset' in the advanced wound care sector. Despite the year-over-year drop, management noted sequential revenue growth and broad-based market share gains across its portfolio.
Term
3 months
“We continue to strengthen our position as a leader in regenerative medicine as customers choose a partner and products they trust. Third quarter revenue increased sequentially, and our market share gains are broad-based across our portfolio. We are defining a sustainable future for advanced wound care as we emerge from the market reset a stronger company anchored by evidence-based living cell products that we believe will be the cornerstone of the market going forward.”
Gary S. Gillheeney, Sr., President, Chief Executive Officer and Chair of the Board
Aemetis achieved a financial inflection point in Q3 2026, posting $5.2 million net income and $24.8 million adjusted EBITDA, driven by 45-Z tax credits and higher-value LCFS pathways.
SiriusPoint Ltd. reported net income available to common shareholders of $86.8 million for the third quarter of 2026, consistent with the prior year period. For the nine months ended September 30, 2026, net income rose to $255.0 million from $203.6 million in 2025, driven by higher net earned premiums and improved underwriting results despite a decrease in net investment income.
FIGS, Inc. is an accelerated filer reporting for the period ending September 30, 2026, with 157,487,979 Class A and 8,283,641 Class B shares outstanding. The company highlights risks including macroeconomic pressures, supply chain challenges in the Middle East, and the impact of U.S. Customs and Border Protection orders on Jordanian manufacturing.
Guardian Pharmacy Services reported a significant increase in net income for the nine months ended September 30, 2026, reaching $54.8 million compared to $27.7 million in the prior year period. This growth was driven by improved gross margins and a substantial $11.2 million gain in other income, despite relatively flat year-over-year revenue of $1.06 billion.
CarGurus reported Q3 2026 revenue of $258.4 million, a 12% year-over-year increase, and GAAP net income from continuing operations of $52.8 million. Alongside the results, the company announced that its Board of Directors authorized a new $250.0 million share repurchase program.
“We delivered strong third-quarter results, with revenue up 12% year-over-year at the high end of guidance and Adjusted EBITDA near the high end. We are bringing products to market faster and building from our marketplace foundation into a broader set of AI enabled solutions across the dealer workflow including building out our inventory pillar with the launch of StockVantage.”
Jason Trevisan, Chief Executive Officer of CarGurus
Camp4 Therapeutics Corp is an emerging growth company focused on developing its RAP Platform for research and development programs. As of November 4, 2026, the company had 62,754,200 shares of common stock outstanding and is currently classified as a non-accelerated filer and smaller reporting company.
EDAP TMS (FocalTherics) reported Q3 2026 revenue of $9.8 million, a 26% increase year-over-year, driven by a 32% increase in U.S. procedure volume and seven Focal One system sales. The company narrowed its full-year 2026 revenue guidance to $50.0-$52.0 million, representing 34% to 39% growth over 2025.
Term
Q3 2026
“We demonstrated steady commercial momentum in the third quarter, highlighted by expanding adoption across multiple new regions and additional system sales in the United States, Turkey, Mexico, and France. U.S. procedure volumes accelerated year-over-year to 32% for the third quarter of 2026, compared to 15% in 2025. Driven by our sustained commercial traction, accelerating technology adoption, and our focus on our HIFU opportunity, we remain highly confident in our growth strategy and on the opportunity ahead as we close out the year.”
Lifetime Brands, Inc. reported net income of $10.6 million for the nine months ended September 30, 2026, a significant recovery from a $45.1 million net loss in the prior year period which was impacted by a $33.2 million goodwill impairment. The company also executed a debt refinancing during the third quarter, resulting in a $2.5 million loss on extinguishment of debt but restructuring its term loan and revolving credit facility.
SPX Technologies Director Brian A. Deck Buys $493K of Stock
Brian A. Deck, Director, bought 3,000 shares of SPX Technologies, Inc. at $164.34 a share, worth $493K in total on Nov 3, 2026. Shares held after the trade: 3,742 (+404.3%).
Guardian Pharmacy Services reported Q3 2026 financial results with revenue of $371.1 million and net income of $19.1 million. The company raised its full-year 2026 guidance for both revenue and Adjusted EBITDA, citing strong organic growth in residents served and successful integration of recent acquisitions.
Term
Q3 2026
“We are very pleased with our third-quarter performance, highlighted by strong resident and prescription growth. Absent the price reductions from the IRA, revenues would have been up high single digits compared to the third quarter of 2025, mostly driven by organic growth.”
Fred Burke, President and Chief Executive Officer
“With favorable industry fundamentals, a substantial runway for growth, and a liquid balance sheet, we believe Guardian is well positioned to generate durable growth and attractive long-term returns for shareholders.”
This document provides definitions for key financial and operational metrics used in Apollo Global Management's reporting, including Net Invested Assets, Net IRR, and Performance Fee-Eligible AUM. It details the components of Athene's retirement services segment and the methodology for calculating origination and perpetual capital. The filing serves as a glossary for understanding the firm's complex credit, equity, and retirement services business model.
Pulsenmore CEO Elazar Sonnenschein Buys $15.7K of Stock
Elazar Sonnenschein, CEO, bought 9,259 shares of Pulsenmore Ltd. at $1.70 a share, worth $15.7K in total on Nov 4, 2026. Shares held after the trade: 892,421 (+1.0%).
For the nine months ended September 30, 2026, Kayne Anderson BDC reported total investment income of $172.0 million and net investment income of $86.6 million. The company experienced significant realized and unrealized losses totaling $51.5 million, resulting in a net increase in net assets from operations of $34.6 million, down from $71.7 million in the prior year period.
ICU Medical reported Q3 2026 revenue of $560.4 million, up from $537.0 million in the prior year, with GAAP net income of $26.8 million compared to a net loss in the same period last year. The company reaffirmed its full-year 2026 guidance, noting it expects results to land at the high end of its previously stated ranges.
Term
Q3 2026
“Third quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.”
PAR Technology reported Q3 2026 revenues of $137.1 million, a 15% increase year-over-year, and narrowed its GAAP net loss to $9.0 million. The company also raised its full-year 2026 revenue guidance to a range of $532.5 million to $536.5 million, citing strong momentum in enterprise deployments and multi-product adoption.
Term
Q3 2026
“Our third quarter performance demonstrated the continued acceleration in growth and profitability we’ve been building toward. We exited the quarter with strong momentum across the business, supported by enterprise deployments, growing multi-product adoption, and a healthy pipeline that positions us well to finish the year strong and carry that progress into 2027.”
Savneet Singh, CEO
“Our operational discipline is allowing us to deliver improving profitability today while continuing to make the long-term investments needed to capture the significant AI and platform opportunity in front of us.”
Chimera Investment Corporation reported a net interest income of $71.2 million for the quarter ended September 30, 2026, up from $65.0 million in the prior year. However, the company experienced significant net unrealized losses on financial instruments at fair value totaling $391 million, contributing to a decrease in total stockholders' equity to $2.17 billion from $2.57 billion at year-end 2025.